MORI, MATTEO

MORI, MATTEO  

Dipartimento di Scienze Farmaceutiche  

Mostra records
Risultati 1 - 20 di 74 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
(S)-Pramipexole and Its Enantiomer, Dexpramipexole : a New Chemoenzymatic Synthesis and Crystallographic Investigation of Key Enantiomeric Intermediates 16-ago-2020 Samuele CiceriPatrizia FerraboschiCarlo CastellanoMatteo MoriFiorella Meneghetti + Article (author) -
5,6-Dimethyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole-2,2-dioxide as new STAT3 inhibitor 1-lug-2019 Villa, S.Mori, M.Meneghetti, F.Pedretti, A.Regazzoni, L.Colombo, D.Gelain A. + Conference Object -
5-(4-Nitrophenyl)furan-2-carboxylic Acid 2-dic-2022 Matteo MoriStefania VillaGiulia CazzanigaFiorella Meneghetti + Article (author) -
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid 18-giu-2020 Matteo MoriFiorella MeneghettiDonatella NavaArianna GelainGiulia CazzanigaStefania VillaElena Pini + Article (author) -
A click chemistry approach to explore a new scaffold for potential antitubercular agents 1-set-2018 Matteo MoriStefania VillaArianna GelainFiorella Meneghetti + Conference Object -
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors 22-lug-2020 Cazzaniga, G.Mori, M.Gelain, A.Pini, E.Meneghetti, F.Villa, S. + Conference Object -
An analytical investigation of hydroxylated cinnamoyl polyamines as biomarkers of commercial bee pollen botanical origin 1-gen-2022 Rita NastiFiorella MeneghettiStefania VillaMatteo MoriGiangiacomo Beretta + Article (author) -
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis 23-nov-2021 Matteo MoriStefania VillaSamuele CiceriDIEGO RODOLFO COLOMBOPatrizia FerraboschiFIORELLA MENEGHETTI Article (author) -
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 1-set-2019 Mori, MatteoGelain, AriannaMeneghetti, FiorellaVilla, Stefania + Article (author) -
Application of chiral bi- and tetra-dentate bispidine-derived ligands in the copper(II)-catalyzed asymmetric Henry reaction 21-lug-2018 Fiorella MeneghettiCarlo CastellanoMatteo Mori + Article (author) -
Benzothiadiazole derivatives endowed with STAT3 inhibition 10-set-2021 A. GelainM. MoriE. GilardoniL. RegazzoniA. PedrettiD. ColomboF. MeneghettiS. Villa + Conference Object -
Biocatalysts for the synthesis of pharmacologically active compounds 6-nov-2020 S. CiceriF. MeneghettiM. MoriP. Ferraboschi + Conference Object -
Biocatalytic synthesis of two pharmacologically active compounds: (S)-pramipexole and its enantiomer, dexpramipexole. 22-lug-2020 CICERI, S.FERRABOSCHI, P.MORI, M.MENEGHETTI, F. + Conference Object -
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition 19-apr-2023 Capelli, DavideCazzaniga, GiuliaMori, MatteoQuaglia, MartinaMeneghetti, FiorellaVilla, Stefania + Article (author) -
Crystal Structure, Hirshfeld Surface Analysis, In-Silico and Antimycotic Investigations of Methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylate 27-dic-2022 Matteo MoriFIORELLA MENEGHETTI + Article (author) -
Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps purpurea 1-gen-2020 Meneghetti, FiorellaFerraboschi, PatriziaMori, MatteoCiceri, Samuele + Article (author) -
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 1-apr-2022 Meneghetti F.Mori M.Castellano C. + Article (author) -
Design and synthesis of novel antituberculars targeting the salicylate synthase (MbtI) 19-giu-2017 S. VillaM. MoriA. GelainF. Meneghetti + Conference Object -
Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents 1-gen-2017 M. MoriS. VillaA. GelainF. Meneghetti + Book Part (author) -
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI). 1-gen-2018 S. VillaM. MoriD. BarloccoA. GelainE. PiniF. Meneghetti + Conference Object -